NCT05311514View on ClinicalTrials.gov

Allogeneic Platelet Lysate Eye Drops for the Treatment of Severe Chronic Ocular Graft-versus-host Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

November 29, 2024

Study Completion Date

November 29, 2024

Conditions

Ocular Graft-versus-host Disease

Interventions

BIOLOGICAL

Allogeneic platelet lysate eye drops

Eye drops

Trial Locations (1)

197089

First Pavlov State Medical University of St. Petersburg, Saint Petersburg

All Listed Sponsors

lead

St. Petersburg State Pavlov Medical University

OTHER

NCT05311514 - Allogeneic Platelet Lysate Eye Drops for the Treatment of Severe Chronic Ocular Graft-versus-host Disease | Biotech Hunter | Biotech Hunter